New anti-abuse formulation of painkiller Oxycodone

It has come to health officials’ attention nationwide that there is a serious rise of abuse of painkillers, especially opioids. Federal officials recently stepped up plans to monitor frequent prescribers and users.

In what could provide a potential boost to those efforts, an oxycodone drug designed to deter tampering — altered so the pill is less easily abused — has received approval from the Food and Drug Administration, Pfizer and Acura Pharmaceuticals announced Monday.

This new formulation is a redesigned drug, an immediate-release form of oxycodone called Oxecta that will be less readily abused than traditional forms of oxycodone. But the tablet has several safeguards built in to frustrate someone trying to inject or snort the pills, such as causing an uncomfortable burn in the nasal passages. The immediate-release medication contains niacin, which is designed to cause uncomfortable flushing and skin irritation if a person takes more than the recommended amount.

The drug isn’t the first form of oxycodone designed to discourage tampering. It joins an extended-release formulation of OxyContin approved last year. But the FDA points out the drug are not completely tamper proof. It said, “The new formulation of OxyContin reduces the likelihood that this drug will be misused and abused, although it cannot completely eliminate this possibility.

Oxecta shouldn't be used in people who have severe asthma, upper-airway obstruction or chronic obstructive pulmonary disease (COPD), drug makers Pfizer and Acura Pharmaceuticals said in a news release. Common adverse reactions include nausea, constipation, vomiting, headache, itchiness, insomnia, dizziness and lack of energy, the authorities said.

Dr. Ananya Mandal

Written by

Dr. Ananya Mandal

Dr. Ananya Mandal is a doctor by profession, lecturer by vocation and a medical writer by passion. She specialized in Clinical Pharmacology after her bachelor's (MBBS). For her, health communication is not just writing complicated reviews for professionals but making medical knowledge understandable and available to the general public as well.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mandal, Ananya. (2018, August 23). New anti-abuse formulation of painkiller Oxycodone. News-Medical. Retrieved on November 24, 2024 from https://www.news-medical.net/news/20110621/New-anti-abuse-formulation-of-painkiller-Oxycodone.aspx.

  • MLA

    Mandal, Ananya. "New anti-abuse formulation of painkiller Oxycodone". News-Medical. 24 November 2024. <https://www.news-medical.net/news/20110621/New-anti-abuse-formulation-of-painkiller-Oxycodone.aspx>.

  • Chicago

    Mandal, Ananya. "New anti-abuse formulation of painkiller Oxycodone". News-Medical. https://www.news-medical.net/news/20110621/New-anti-abuse-formulation-of-painkiller-Oxycodone.aspx. (accessed November 24, 2024).

  • Harvard

    Mandal, Ananya. 2018. New anti-abuse formulation of painkiller Oxycodone. News-Medical, viewed 24 November 2024, https://www.news-medical.net/news/20110621/New-anti-abuse-formulation-of-painkiller-Oxycodone.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Early RSV vaccination in pregnancy provides best protection for newborns